CLRB - Cellectar Bio slips 23% after pricing $20M public offering June, 03 2020 09:19 AM Cellectar Biosciences Inc. Cellectar Biosciences (NASDAQ:CLRB) has priced its public offering for gross proceeds of $20M.More news on: Cellectar Biosciences, Inc., Healthcare stocks news, , Stocks on the move, Read more ...